Cite
Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial κ-opioid agonist effect
MLA
Kris Ramabadran, et al. “Synthesis and Biological Evaluation of the Major Metabolite of Atomoxetine: Elucidation of a Partial κ-Opioid Agonist Effect.” Bioorganic & Medicinal Chemistry Letters, vol. 14, Aug. 2004, pp. 4083–85. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d6e46da7e31a496e1ee4483b839289c9&authtype=sso&custid=ns315887.
APA
Kris Ramabadran, Christopher J. Creighton, Jingchun Liu, Allen B. Reitz, Michael J. Orsini, & Patrick E. Ciccone. (2004). Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial κ-opioid agonist effect. Bioorganic & Medicinal Chemistry Letters, 14, 4083–4085.
Chicago
Kris Ramabadran, Christopher J. Creighton, Jingchun Liu, Allen B. Reitz, Michael J. Orsini, and Patrick E. Ciccone. 2004. “Synthesis and Biological Evaluation of the Major Metabolite of Atomoxetine: Elucidation of a Partial κ-Opioid Agonist Effect.” Bioorganic & Medicinal Chemistry Letters 14 (August): 4083–85. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d6e46da7e31a496e1ee4483b839289c9&authtype=sso&custid=ns315887.